Yi Shen

Guangzhou University of Chinese Medicine — China

Medicine · Health Sciences

26h-index3.0kcitations128works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Myasthenia Gravis and Thymoma(24), Lung Cancer Treatments and Mutations(19), Meningioma and schwannoma management(18), Pituitary Gland Disorders and Treatments(17), Lung Cancer Diagnosis and Treatment(16)

Publications123 total

Allosteric activation of a cell-type-specific GPR120 inhibits amyloid pathology of Alzheimer’s disease
Nature Aging·2025Open Access
Network pharmacology and molecular dynamics simulation elucidate the potential mechanism of Batatasin-III in Bletilla striata against ulcerative colitis
Scientific Reports·2025· 2 citedOpen Access
Perioperative outcomes in lung cancer: transfer vs. outpatient admission routes
BMC Surgery·2025Open Access
Time-updated patterns of hemoglobin and hematocrit and the risk of CKD progression
Frontiers in Endocrinology·2025Open Access
A multimodal deep learning framework with contrastive learning and multi-instance learning for endometrial cancer preoperative risk stratification
2025Open Access
Multi-domain Fusion Method for Power Business Data on Data Middle Platform
Communications in computer and information science·2025
A 0.71nJ, 1.53GS/s Throughput 256-FFT Using Floating Point Analog Computation
2025
Which is the best surgical approach for thymectomy: robot-assisted thoracoscopic surgery (RATS), video-assisted thoracoscopic surgery (VATS), thoracotomy (TORA) or subxiphoid video-assisted thoracoscopic surgery (SPT)?—a systematic review and network meta-analysis
Gland Surgery·2025Open Access
Su1766: A STUDY OF CLINICAL CHARACTERISTICS IN 43 PATIENTS WITH PORTO-SINUSOIDAL VASCULAR DISEASE
Gastroenterology·2025
SAT-237 A study of clinical characteristics in 43 patients with porto- sinusoidal vascular disease
Journal of Hepatology·2025
Exploration potential sepsis–ferroptosis mechanisms through the use of CETSA technology and network pharmacology
Scientific Reports·2025· 1 citedOpen Access
Intravasation‐On‐µDevice (INVADE): Engineering Dynamic Vascular Interfaces to Study Cancer Cell Intravasation
Advanced Materials·2025· 5 citedOpen Access
CTSO and HLA-DQA1 as biomarkers in sepsis-associated ARDS: insights from RNA sequencing and immune infiltration analysis
BMC Infectious Diseases·2025· 1 citedOpen Access
S100P is a core gene for diagnosing and predicting the prognosis of sepsis
Scientific Reports·2025· 1 citedOpen Access
Allosteric activation of a cell-type specific GPR120 rescues cognition and extends lifespan of Alzheimer’s disease
2024Open Access
SPP1 is a plasma biomarker associated with the dia gnosis and prediction of prognosis in sepsis
Scientific Reports·2024· 3 citedOpen Access
235. A NOVEL TUMOR STAGING SYSTEM INCORPORATING CN STATUS FOR STRATIFYING EARLY STAGE ESOPHAGEAL SQUAMOUS CELL CARCINOMA PATIENTS AFTER TRIMODAL THERAPY
Diseases of the Esophagus·2024Open Access
Establishment and verification of novel TNM staging system for lung mucinous adenocarcinoma
BMC Cancer·2024· 1 citedOpen Access
Power-efficient 12-bit 800 MS/s voltage-time hybrid domain ADC with split TDC in 28 nm CMOS
Microelectronics Journal·2024· 1 cited
THU-532 New insight of liver fibrosis: altered chromatin accessibility in hepatic stellate cells
Journal of Hepatology·2024Open Access
page 1 of 7Next →

Frequent Co-authors

Chun Chen(19), Ke‐Neng Chen(17), Yongyu Liu(16), Yu Liu(13), Liewen Pang(12), Xinming Zhou(12), Jianhua Fu(11), Yucheng Wei(11), Peng Zhang(11), Yangchun Liu(11), Wentao Fang(11), Lin Xu(10), Zhitao Gu(10), Yun Wang(10), Zhentao Yu(10), Hezhong Chen(9), Weimin Mao(8), Qun Wang(7), Xiaofei Li(7), Shidong Xu(7)